(Q43037932)

English

Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment

scientific article published in October 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

object named as

Ivan Hirsch

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Federica Bozzano

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Antonino Picciotto

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Paola Costa

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Francesco Marras

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Valentina Fazio

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Daniel Olive

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lorenzo Moretta

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Andrea De Maria

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2905-2914

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Viral modulation of NK cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Activation of natural killer cells during acute infection with hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses indu

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Natural killer cells and dendritic cells: rendezvous in abused tissues

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Early liaisons between cells of the innate immune system in inflamed peripheral tissues.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

NK cells at the interface between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

CD107a as a functional marker for the identification of natural killer cell activity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

The dialogue between human natural killer cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased susceptibility to apoptosis of CD56dimCD16+ NK cells induces the enrichment of IFN-gamma-producing CD56bright cells in tuberculous pleurisy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201041361

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43037932&oldid=1978292777"